Niacin Vitamin B3 50 mg
60/100
Review before taking
- Niacin: 50mg is 1.4× the Tolerable Upper Intake Level (35mg)
- 100% of ingredients have research evidence
C
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Safety Alerts
⚠️ Niacin: 50mg is 1.4× the Tolerable Upper Intake Level (35mg)
The safety score is low because the 50mg dose of niacin exceeds the recommended maximum daily limit of 35mg.
Label Data
1 Tablet(s)
Serving Size
270
Servings
Vitamin
Product Type
100%
Evidence Coverage
Supplement Facts — Evidence Check
50 mg
(313% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 1.4× (UL: 35 mg)
📚 193 studies (Tier A: 5, B: 63)
Other Ingredients
Microcrystalline Cellulose
Silicon Dioxide
Rice Bran Extract
Rice Husk
Gum Acacia
Sunflower Oil
Maltodextrin
Sunflower Lecithin
Palm Oil
Guar Gum
Label Claims — Verification
❓
Nutrient
❓
All Other
All Other (97% of products)
Structure/Function (86% of products)
Nutrient (36% of products)
Target Groups
Adult (18 - 50 Years)
Product Information
📋 Directions for Use
Suggested use: Adults, as a dietary supplement, take one (1) tablet three times daily.
⚠️ Warnings & Precautions
Keep out of reach of children.
Do not use if safety seal is broken.
If you are nursing, pregnant, taking medication or have a medical condition, consult your physician before taking this product.
🧪 Formulation Notes
Niacin Vitamin B3 50 mg Per tablet
Mini Tabs
Additional Information
Providing quality products since 2001.
Product Details
UPC / SKU
8 10094 21296 4
DSLD Entry Date
2025-02-23
Product Type
Vitamin
Form
Tablet or Pill
Brand
Dr. Mercola
DSLD ID
327186
Data Updated
2026-04-11
Research Evidence
241
Research Sources
55
Avg Quality Score
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A
Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
A
Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
A
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
A
Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
B
Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Compare Similar Products
Rezistaf
LifeLink
100
Coenzymated B-3 25 mg
Source Naturals
100
Vitamin B Complex
Simply Supplements
100
Test X180 Boost
Force Factor
100
8-Hour Alert
MHP Maximum Human Performance
100